Counterfeit versions of 'next Ozempic' retatrutide are being hawked by Chinese website GorillaHealing.com even though real version won't be approved until at least 2026 Knock-off versions of Eli Lilly's retatrutide, hailed as a potential 'new Ozempic', are being sold directly to US consumers via Chinese websites The unapproved drugs are also finding their way into consumer hands via adverts on social media platforms, and even collaborations with influencers See more Daily Mail on Google - save us as a Preferred Source Knock-off versions of Eli Lilly's retatrutide, hailed as a potential 'new Ozempic', are being sold directly to US consumers via Chinese websites despite being years away from regulatory approval
Subclinical hypothyroidism becomes more common in women over 40, which can slow metabolism and make weight loss more difficult
Creeping fat formation and interaction with intestinal disease in Crohns disease
It is designed to curb appetite and reduce cravings, aiding in weight management
- OTC drugs drive accessibility & scale
Both classes reduce hunger, so combined use can drive caloric intake very low